Showing posts with label applaud medical. Show all posts
Showing posts with label applaud medical. Show all posts

Thursday 3 June 2021

 

US and France healthcare startups to team up to drive growth in the sector

As pandemic continues to hamper international interactions, the US and France startups are collaborating with BE Health in Taiwan. They have closed the venture capital funding rounds recently with more than US$14 million in total successfully. BE Health delivers the unique strengths of its thriving ecosystem and is supporting both local and international startups.

Applaud Medical, a clinical-stage company based in San Francisco which addresses the painful condition of kidney stones, with an innovative, non-invasive treatment, completed US$11 million fundraisings; the recent investment will enable it to expand the company, as well as broaden and accelerate product development.  RDS, a developer of a wearable health tracking device which continuously measures vital sign parameters, announced that it had closed their Seeding Round of EUR3 million (US$3.67 million) in the first quarter of 2021.

Both these companies are now aiming at the healthcare sector by forming a partnership with BE Health. Being the only two shareholders from the east, BE and Taipei Medical University are thrilled to be their partners. This partnership will enable them to validate the high-quality prototype-making. BE Health will consistently work with these companies for future expansion, conduct clinical trials, and increase product market traction.